Brought to you by www.DealSearchOnline.com
 

September 23, 2013 Issue:
 

Recent Health Care M&A Deals

Hospitals

Acquirer

Target

Price

Fresenius SE & Co. KGaA

43 Hospitals

$4.1 billion

Providence Health & Services

Saint John’s Health Center

N/A

Houston Methodist

CHRISTUS St. Catherine & CHRISTUS St. John

N/A

Medical Devices

Acquirer

Target

Price

Golden Equity Investments

Innovative Medical Device Solutions

N/A

Pharmaceuticals

Acquirer

Target

Price

Cellceutix

PolyMedix Assets

N/A

Chiesi Farmaceutici

Cornerstone Therapeutics

$251.75 million

 
Technology Deal of the Week
It was a quiet week for deal making on the Technology side of health care. No billion-dollar bids, no hostile takeovers, no drama. Just a nice offer of $9.50 per share for 100% ownership of Cornerstone Therapeutics Inc. (NASDAQ: CTRX), made by the Italian pharma company, Chiesi Farmaceutici S.p.A. The price works out to a total of $251.7 million for the 42% of Cornerstone shares that Chiesi doesn’t already own, and comes to approximately 78% over Cornerstone’s closing price of $5.35 on February 15, 2013, the last trading day prior to Chiesi’s initial written proposal. Jefferies International Limited is serving as financial advisor to Chiesi, and Morgan, Lewis & Bockius is its legal advisor on the deal. Lazard is serving as financial advisor to Cornerstone, and Clifford Chance is its legal advisor……Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
 
Charted Territory
The usually quiet Rehabilitation sector got a jolt last week, as Senior Housing Properties Trust (NYSE: SNH) announced the sale of two rehabilitation hospitals to a joint venture comprised of affiliates of The Sanders Trust, LLC and Harrison Street Real Estate Capital, LLC for $90 million. That’s a good chunk of change for this sector, in which the deals are typically private and local. So far this year, only eight transactions have been made public, and this deal is just the second to include a price. Data gathered in the previous five years seem to depict a roller coaster ride in both deal volume and deal values, with the highest number of deals announced – 27 in 2008 – accompanied by one of the lowest combined totals in the five-year period, just $43 million. And the $1.3 billion total turned in in 2011 was the result of a single deal, Kindred Healthcare’s (NYSE: KND) acquisition of RehabCare Group, Inc. (NYSE: RHB). Which just goes to show, you can’t judge a sector by its deal values.
 
Mergers and Acquisitions in the Rehabilitation Sector, 2008 to 2012

 

2012

2011

2010

2009

2008

Deal volume

18

9

12

11

27

% change, y-o-y

100%

-25%

9%

-59%

69%

Deal value (millions)

$750

$1,318

$237

$22

$43

% change, y-o-y

-43%

457%

973%

-49%

-90%

Source: Irving Levin Associates, Inc., September 20, 2013
Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today
 
Services Deal of the Week
It’s back on. German hospital system Rhoen-Klinikum AG (OTCBB: RKAGY) announced once again that it will sell most of its hospitals to rival Fresenius SE & Co. KGaA (NYSE: FMS), this time for $4.1 billion. Some readers may recall a similar announcement was made in Q2:12, when Fresenius offered $3.9 billion for all 53 hospitals (16,000 beds) and 39 healthcare centers in Germany. The deal was scuttled when privately held hospital system Asklepios acquired enough shares in Rhoen to kill the transaction. This time around, just 43 hospitals and 15 outpatient centers are part of the deal, representing about two-thirds of Rhoen’s revenues. Rhoen will hold on to its specialized clinics and university teaching hospitals……Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
 
In the Pipeline
Nanosphere, Inc., (NASDAQ: NSPH), the molecular diagnostics company with the Mork-ish name, closed its previously announced public offering of 17,250,000 shares of its common stock at the molecular price of $1.75 per share. Piper Jaffray & Co. acted as the sole book-running manager and Canaccord Genuity Inc. and Cowen and Company, LLC acted as co-managers for the offering. Net proceeds from the sale, minus the usual underwriting discounts and commissions, are expected to be around $27.7 million, which is already earmarked for “general corporate purposes and working capital.” Nano, nano….Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
 
Just Published – The Hospital M&A Market Report, 2013- Save $50
The Hospital M&A Market Report, 2013 gives you critical details on the deals associated with the recent trend in the hospital acquisition market toward middle-market targets, plus key contact information. There’s no quicker way to get current on the hospital M&A market or review historic hospital M&A data. Reference the facts and figures you need to evaluate a target, assess your hospital’s potential asking price or complete a consulting project. For a limited time, save $50 instantly by entering coupon code 50_off at checkout!
Go to http://www.levinassociates.com/hospital-description or call 800-248-1668 to order today!
 
Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 800-248-1668 to learn about our frequency discounts. Go to http://www.dealsearchonline.com, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 800-248-1668 to learn about our frequency discounts.
 
Webcast Calendar…Click here to see more